Cite
HARVARD Citation
Tibaldi, C. (2014). Research Highlights: Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small-cell lung cancer. Pharmacogenomics. pp. 133-135. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tibaldi, C. (2014). Research Highlights: Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small-cell lung cancer. Pharmacogenomics. pp. 133-135. [Online].